Interestingly, we found that α7-nAChRs activation showed the reduction of both exogenous and endogenous αSyn, which was confirmed in αSyn stable transgenic cell line and a mouse model of PD using the chronic MPTP/P treatment. Here, CHRNA7 is linked to Parkinson disease.